BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu H, Yuan SJ, Chen YT, Xie YB, Cui L, Yang WZ, Yang DX, Tian YT. Preclinical evaluation of herpes simplex virus armed with granulocyte-macrophage colony-stimulating factor in pancreatic carcinoma. World J Gastroenterol 2013; 19(31): 5138-5143 [PMID: 23964149 DOI: 10.3748/wjg.v19.i31.5138]
URL: https://www.wjgnet.com/1007-9327/full/v19/i31/5138.htm
Number Citing Articles
1
Evelyne Tassone, Michela Muscolini, Nadine van Montfoort, John Hiscott. Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?Cytokine & Growth Factor Reviews 2020; 56: 141 doi: 10.1016/j.cytogfr.2020.07.015
2
Lihong Wang, Louisa S Chard Dunmall, Zhenguo Cheng, Yaohe Wang. Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatmentJournal for ImmunoTherapy of Cancer 2022; 10(5): e004167 doi: 10.1136/jitc-2021-004167
3
Ding Wei, Qian Li, Xi-Long Wang, Yuan Wang, Jing Xu, Fei Feng, Gang Nan, Bin Wang, Can Li, Ting Guo, Zhi-Nan Chen, Huijie Bian. Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing miceJournal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0271-1
4
Nicholas Denton, Chun-Yu Chen, Thomas Scott, Timothy Cripe. Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?Biomedicines 2016; 4(3): 13 doi: 10.3390/biomedicines4030013
5
Dong Wang, Xian-Wang Wang, Xiao-Chun Peng, Ying Xiang, Shi-Bao Song, Ying-Ying Wang, Lin Chen, Victoria W. Xin, Yan-Ning Lyu, Jiafu Ji, Zhao-Wu Ma, Cheng-Bin Li, Hong-Wu Xin. CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus researchCancer Gene Therapy 2018; 25(5-6): 93 doi: 10.1038/s41417-018-0016-3
6
Ludi Yang, Xiang Gu, Jie Yu, Shengfang Ge, Xianqun Fan. Oncolytic Virotherapy: From Bench to BedsideFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.790150
7
Xianwang Wang, Yihua Shen, Xingxia Wan, Xiaoqing Hu, Wen-Qi Cai, Zijun Wu, Qiang Xin, Xiaoqing Liu, Jingang Gui, Hong-Yi Xin, Hong-Wu Xin. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapyJournal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04360-8
8
Kaitlyn J. Kelly, Joyce Wong, Mithat Gönen, Peter Allen, Murray Brennan, Daniel Coit, Yuman Fong. Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic CancerEBioMedicine 2016; 7: 94 doi: 10.1016/j.ebiom.2016.03.043
9
Nicholas L. Denton, Chun-Yu Chen, Brian Hutzen, Mark A. Currier, Thomas Scott, Brooke Nartker, Jennifer L. Leddon, Pin-Yi Wang, Rachelle Srinivas, Kevin A. Cassady, William F. Goins, Timothy P. Cripe. Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune MicroenvironmentMolecular Therapy - Oncolytics 2018; 11: 62 doi: 10.1016/j.omto.2018.10.001
10
Molly C. Holbrook, Dakota W. Goad, Valery Z. Grdzelishvili. Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and SolutionsCancers 2021; 13(5): 1171 doi: 10.3390/cancers13051171
11
Simona Ruxandra Volovat, Dragos Viorel Scripcariu, Ingrid Andrada Vasilache, Cati Raluca Stolniceanu, Constantin Volovat, Iolanda Georgiana Augustin, Cristian Constantin Volovat, Madalina-Raluca Ostafe, Slevoacă-Grigore Andreea-Voichița, Toni Bejusca-Vieriu, Cristian Virgil Lungulescu, Daniel Sur, Diana Boboc. Oncolytic Virotherapy: A New Paradigm in Cancer ImmunotherapyInternational Journal of Molecular Sciences 2024; 25(2): 1180 doi: 10.3390/ijms25021180
12
Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander Eggermont, Philippe Erbs, Jitka Fucikova, Jérôme Galon, Jean-Marc Limacher, Xavier Preville, Catherine Sautès-Fridman, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Trial Watch—Oncolytic viruses and cancer therapyOncoImmunology 2016; 5(2): e1117740 doi: 10.1080/2162402X.2015.1117740
13
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Philippe Erbs, Jean-Marc Limacher, Xavier Preville, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Trial Watch:OncoImmunology 2014; 3(6): e28694 doi: 10.4161/onci.28694
14
Giulia Mesiano, Roberta Zini, Giulia Montagner, Nicoletta Bianchi, Rossella Manfredini, Antonella Chillemi, Massimo Aglietta, Giovanni Grignani, Ilaria Lampronti, Erika Fiorino, Fabio Malavasi, Dario Sangiolo, Roberto Gambari, Davide Ferrari. Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-lnduced Killer CellsMolecular Medicine 2017; 23(1): 235 doi: 10.2119/molmed.2017.00084
15
Maryum Nisar, Rehan Zafar Paracha, Sidra Adil, Sumair Naseem Qureshi, Hussnain Ahmed Janjua. An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic CancerFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.875188
16
Altaf Mohammed, Naveena Janakiram, Shubham Pant, Chinthalapally Rao. Molecular Targeted Intervention for Pancreatic CancerCancers 2015; 7(3): 1499 doi: 10.3390/cancers7030850
17
R. Eftimiea, G. Eftimie. Tumour-Associated Macrophages and Oncolytic Virotherapies: A Mathematical Investigation into a Complex DynamicsLetters in Biomathematics 2018; 5(2) doi: 10.30707/LiB5.2Eftimiea